top of page
Home: Welcome

Post-Doc work published in JAMA

"HPV vaccination has been recommended for routine use in US women since June 2006. Studies from 2022 and 2023 indicated a 12% per year decline (overall, 65% reduction) in cervical cancer incidence during 2012 to 2019 among US women younger than 25 years who likely benefited from HPV vaccination."

About Us
Data Drives Decisions

Established in 2020, Clinical Analytics and Decision Science (CADS) lab is located in Charleston and reflects the diverse energy of the area. Here at CADS lab, we offer a comprehensive environment conducive to high-impact research. Our team encompasses a broad range of disease area expertise, methodological skill sets, and a track record of publications in prestigious medical journals. Since its inception, the lab has been highly invested in solving complex real-world issues using state-of-the-art healthcare data analytics in combination with clinical decision science.  In line with MUSC's "We are changing what's possible", we strive for excellence in research, provide training opportunities for next generation of scientists, and offer engaging courses in data analytics and decision science. 

Research domains

Digital binary data on computer screen. Close-up with small dept.jpg

Data analytics 

shutterstock_1151595443.jpg

Decision Science/
Simulation modeling

Home: Quote

In The Media I Washington Post

Washington post.png

Recent studies by the CADS lab featured in The Washington Post

December 5, 2024

Recognition I Podcast

CADS Lab member, Dr. Trisha Amboree, was featured on the Cervivor Podcast to discuss her recent work.

In this episode, Dr. Amboree discusses "Cancer Elimination Day of Action" - exploring health disparities in cervical cancer prevention and the importance of community engagement.

November17, 2024

In The Media I NY Times  

Screenshot 2024-08-23 132123.png

February 22, 2024

Latest

News

Dr. Sonawane received a G08 award from the National Institute on Health to support her cancer data visualization tool project, SC SPOT.

September 9, 2024

News 

New $4 million grant to determine optimal anal cancer screening among women with lower genital tract precancerous or cancer 

Dr. Deshmukh and colleagues (Dr. Keith Sigel [Mt. Sinai] and Dr. Elizabeth Chiao [MD Anderson Cancer Center]) received a grant from NCI to determine effective and cost-effective screening strategies for anal cancer prevention among high-risk women with a history cervical, vaginal, or vulvar cancer or precancerous

September 1, 2021

News

Explore more of our


and

 

bottom of page